Posted in | News | Medical Robotics

Korean-Based Dongbang Healthdyne to Support Indirect Sales and Service for Health Robotics

Health Robotics recently declared that Korean-based market leader Dongbang Healthdyne will support a new indirect sales and service channel for its high-efficiency i.v.STATION ONCO, i.v.STATION, and i.v.SOFT products.

By promoting affordable and safe Intravenous Admixture Compounding Automation to hospitals Health Robotics will remain as a pioneer in the global healthcare industry.

According to Dongbang Healthdyne' President, Byung Ahn, with growing life expectancy of its population, Korea has witnessed an increase of cancer patients up to three times than before. Hospitals in Korea are challenged with compounding Oncology IV preparations. According to  market research, Health Robotics has been flourishing with the development of its G2 i.v.STATION ONCO.

Health Robotics' Executive Vice President, Gaspar DeViedma says that Health Robotics' G2 Cancer Therapy Compounding robot for syringes and I.V. Bags has become significant with the launch of i.v.STATION ONCO within the worldwide healthcare market. i.v.STATION ONCO’s technological innovations include its potential to leverage pre-attached lines to IV Bags; automatic tamper-evident syringe capping; small footprint range 15% to 25% of the size or weight of other IV Robots; RFID support and rapid throughput up to 40 doses per hour instead of 20 doses per hour. In addition to i.v.STATION and i.v.SOFT, Health Robotics will also promote i.v.STATION ONCO to have a leading position in the industrial markets of Korea that will ultimately lead to a significant expansion.

Source: https://www.omnicell.com/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Health Robotics. (2022, June 22). Korean-Based Dongbang Healthdyne to Support Indirect Sales and Service for Health Robotics. AZoRobotics. Retrieved on February 28, 2024 from https://www.azorobotics.com/News.aspx?newsID=2780.

  • MLA

    Health Robotics. "Korean-Based Dongbang Healthdyne to Support Indirect Sales and Service for Health Robotics". AZoRobotics. 28 February 2024. <https://www.azorobotics.com/News.aspx?newsID=2780>.

  • Chicago

    Health Robotics. "Korean-Based Dongbang Healthdyne to Support Indirect Sales and Service for Health Robotics". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=2780. (accessed February 28, 2024).

  • Harvard

    Health Robotics. 2022. Korean-Based Dongbang Healthdyne to Support Indirect Sales and Service for Health Robotics. AZoRobotics, viewed 28 February 2024, https://www.azorobotics.com/News.aspx?newsID=2780.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.